INTEGRATED BIOPHARMA INC (INBP) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-25

INTEGRATED BIOPHARMA INC (INBP) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-25. 2 Form 8-K material event filings were reported by INBP in the last 90 days. InsiderAlpha tracks every INBP SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About INTEGRATED BIOPHARMA INC (INBP)

SEC CIK	0001016504

90-Day SEC Filing Activity

Form 4 filings (90d)	4
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-06-25

Recent INBP Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-04-15	DeSantis Damon	Director	G — Bona-fide gift	8.97M	$0.00	—	SEC
2026-04-15	Milmoe William H.	Director	G — Bona-fide gift	2.24M	$0.00	—	SEC
2026-04-15	Milmoe William H.	Director	G — Bona-fide gift	8.97M	$0.00	—	SEC
2026-04-15	DESANTIS CARL	10% Owner	G — Bona-fide gift	2.24M	$0.00	—	SEC
2026-04-15	DESANTIS CARL	10% Owner	G — Bona-fide gift	8.97M	$0.00	—	SEC
2026-04-15	DeSantis Damon	Director	G — Bona-fide gift	2.24M	$0.00	—	SEC
2026-03-24	Milmoe William H.	Director	G — Bona-fide gift	1.36M	$0.00	—	SEC
2026-03-24	DeSantis Damon	Director	G — Bona-fide gift	1.36M	$0.00	—	SEC
2026-03-24	DeSantis Damon	Director	G — Bona-fide gift	7.4K	$0.00	—	SEC
2026-03-24	Milmoe William H.	Director	G — Bona-fide gift	7.4K	$0.00	—	SEC
2026-03-24	DESANTIS CARL	10% Owner	G — Bona-fide gift	1.36M	$0.00	—	SEC
2026-03-24	DESANTIS CARL	10% Owner	G — Bona-fide gift	7.4K	$0.00	—	SEC
2025-05-30	Milmoe William H.	Director	A — Grant or award	50.0K	$0.09	$4K	SEC
2025-05-21	RIVA SHEPPARD	Co-Chief Executive Officer	A — Grant or award	144.4K	$0.09	$13K	SEC
2025-05-21	Masi Dina	Chief Financial Officer	A — Grant or award	135.0K	$0.09	$12K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for INTEGRATED BIOPHARMA INC (INBP). Updated in real time as new filings are submitted to the SEC.

Most-Active INBP Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Milmoe William H.	1	—
Canarick Robert	1	—
FRIEDMAN ERIC J	1	—
DeSantis Damon	1	—

Recent INBP Form 8-K Material Events

2026-07-02 — Item 1.01, 1.02, 9.01 [SEC]
2026-05-08 — Item 2.02, 9.01 [SEC]
2026-04-15 — Item 8.01, 9.01 · Financing · neutral [SEC]
Integrated BioPharma and its subsidiary Manhattan Drug Company received notification from PNC Bank that their line of credit expiration date has been extended from April 15, 2026 to July 14, 2026. This is a routine extension of an existing credit facility with no change to terms
2026-02-18 — Item 1.01, 9.01 · Contract · negative [SEC]
Integrated Biopharma's subsidiary Manhattan Drug Company amended its lease with Vitamin Realty (owned by company insiders) on February 17, 2026. The amendment reduces leased square footage by 6,080 sq ft but increases annual rent from $845,966 to $1,100,950 (30% increase), extend

Recent Insider Filings

2026-06-25 — DeSantis Damon (Director)
2026-06-25 — FRIEDMAN ERIC J (Director)
2026-06-25 — Canarick Robert (Director)
2026-06-25 — Milmoe William H. (Director)
2026-04-17 — Milmoe William H. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in INBP insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

INBP Insider Trading — FAQ

What is the latest insider trade for INBP?: INTEGRATED BIOPHARMA INC (INBP) had 4 insider filings in the last 90 days, with the most recent on 2026-06-25. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying INBP stock?: 0 insider purchases of INBP were filed in the last 90 days.
How many insiders are selling INBP stock?: 0 insider sales of INBP were filed in the last 90 days.
Where can I see INBP SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every INBP SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live INBP dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.